References
1. Singh N, Paterson DL. Aspergillus infections in transplant
recipients. Clin Microbiol Rev 2005; 18:44-69.
2. Levin T, Suh B, Beltramo D, Samuel R. Aspergillus mediastinitis
following orthotopic heart transplantation: case report and review of
the literature. Transpl Infect Dis 2004; 6:129-31.
3. Chou NK, Wang JL, Chi NH, et al. Surgical treatment of mediastinitis
after cardiac transplantation. Transplant Proc 2008; 40:2629-30.
4. Forestier E, Remy V, Lesens O, et al. A case of Aspergillus
mediastinitis after heart transplantation successfully treated with
liposomal amphotericin B, caspofungin and voriconazole. Eur J Clin
Microbiol 2005; 24:347-9.
5. Zbinden A, Imhof A, Wilhelm MJ, et al. Fatal outcome after heart
transplantation caused by Aspergillus lentulus. Transpl Infect Dis 2012;
14:E60-3.
6. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis:
clinical practice guidelines of the Infectious Diseases Society of
America. Clin Infect Dis 2008; 46:327-60.
7. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal
agent. Clin Infect Dis 2003; 36:630-7.
8. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus
amphotericin B for primary therapy of invasive aspergillosis. N Engl J
Med 2002; 347:408-15.
9. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE.
Voriconazole concentration in human aqueous humor and plasma during
topical or combined topical and systemic administration for fungal
keratitis. Antimicrob Agents Chemother 2007; 51:239-44.
10. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant
fungal endophthalmitis: case series. Retina 2006; 26:935-9.
11. Jurkunas UV, Langston DP, Colby K. Use of voriconazole in the
treatment of fungal keratitis. Int Ophthalmol Clin 2007; 47:47-59.
12. Tortorano AM, Viviani MA, Biraghi E, et al. In vitro testing of
fungicidal activity of biocides against Aspergillus fumigatus. J Med
Microbiol 2005; 54:955-7.
13. Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC.
Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin
for fungal keratitis in Bangladesh. Br J Ophthalmol 1998; 82:919-25.
14. Tekce AY, Erbay A, Cabadak H, Yagci S, Karabiber N, Sen S.
Pan-resistant Acinetobacter baumannii mediastinitis treated successfully
with tigecycline: a case report. Surg Infect 2011; 12:141-3.
15. Lachanas E, Tomos P, Sfyras N, Miyakis S, Kostakis A. Acinetobacter
baumannii mediastinitis after cardiopulmonary bypass: case report and
literature review. Surg Infect 2008; 9:201-4.
16. George RS, Birks EJ, Haj-Yahia S, et al. Acinetobacter mediastinitis
in a heart transplant patient. Ann Thorac Surg 2006; 82:715-6.
17. Jain R MS, Motukupally SR, Jain M. Use of topical colistin in
multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis.
Cornea. 2014; 33:923-7.